X0508 4 2025-02-05 false 0001710072 Edgewise Therapeutics, Inc. EWTX 0001853109 Derakhshan Behrad C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET BOULDER CO 80301 false true false false Chief Business Officer false Common Stock 2025-02-05 4 M false 10000.00 1.93 A 26837.00 D Common Stock 2025-02-05 4 S false 10000.00 30.03 D 16837.00 D Stock Option (Right to Buy) 1.93 2025-02-05 4 M false 10000.00 0.00 D 2024-12-03 2030-12-15 Common Stock 10000.00 92929.00 D Includes 1,716 shares purchased on November 15, 2024 pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 30, 2024. The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $30.00 to $30.13, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ John R Moore Attorney-in-Fact for Behrad Derakhshan 2025-02-07